Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 60Neoplasms 59Lung Neoplasms 32Prostatic Neoplasms 24Colorectal Neoplasms 24Carcinoma, Non-Small-Cell Lung 21Neoplastic Cells, Circulating 20Head and Neck Neoplasms 19Pancreatic Neoplasms 17Melanoma 14Ovarian Neoplasms 13Carcinoma, Hepatocellular 12Esophageal Neoplasms 10Colonic Neoplasms 10Uterine Cervical Neoplasms 9Liver Neoplasms 9Glioma 9Squamous Cell Carcinoma of Head and Neck 8Multiple Myeloma 8Leukemia, Myeloid, Acute 8Sarcoma 7Neoplasm Metastasis 7Endometrial Neoplasms 7Stomach Neoplasms 6Neoplasm, Residual 6Myeloproliferative Disorders 6Leukemia 6Kidney Neoplasms 6Gastrointestinal Neoplasms 6Carcinoma, Renal Cell 6

Interventions

Microarray Analysis 2In Situ Hybridization, Fluorescence 2Cytogenetic Analysis 2Biopsy 2Watchful Waiting 1Urination 1Tissue Banks 1Surveys and Questionnaires 1Radioimmunodetection 1Molecular Diagnostic Techniques 1Immunohistochemistry 1Fentanyl 1Blood Specimen Collection 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Monoclonal Gammopathy of Undetermined Significance × Blood Specimen Collection × Clear all
NCT06644625 2026-01-20

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Wake Forest University Health Sciences

Recruiting
1,665 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡